VESPER-JM: once-monthly berobenatide in Japan

This is a registry record, not a result. A trial being listed, recruiting or completed says nothing by itself about whether the compound works or is safe.

Registry numberNCT07794774
StatusNot yet recruiting
PhasePhase 3
SponsorPfizer
Enrollment197 participants
DesignNot stated
ConditionsObesity
InterventionsBerobenatide; Placebo
StartSep 28, 2026
Primary completionFeb 21, 2029
Study completionNot stated
Results postedNot yet
Registry last updatedNot stated

Source: ClinicalTrials.gov (U.S. National Library of Medicine). See the trial changes feed for what has changed recently.

Share thisFacebookXEmail